Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States
Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States
复制标题
DOI：
10.1016/j.bbmt.2015.11.001
复制
发表时间：
2016-01-01
影响因子：
4.3
通讯作者：
Kodera, Yoshihisa
中科院分区：
文献类型：
--
作者：
Apperley, Jane;Niederwieser, Dietger;Kodera, Yoshihisa
全球血液和骨髓移植网络（WBMT）的主要项目之一是在世界新兴国家推广造血干细胞移植（HSCT）。对于这些国家来说，来自家庭成员的 HLA 单倍体 HSCT (haplo-HSCT) 因其成本效益而成为一种有吸引力的方法。为了了解单倍体造血干细胞移植的现状，包括最新趋势，WBMT 邀请了来自 3 个地区（亚洲、欧洲和北美）主要移植中心的演讲者在其年度 WBMT 联席会议上发表演讲。本文包含这 3 位发言人的直接报告以及 2 位 WBMT 发言人的介绍，他们讨论了全球移植活动调查的数据。然而，必须强调的是，本文中提出的单倍体造血干细胞移植的某些有希望的结果是在经验丰富的研究所获得的。 (C) 2016 年美国血液和骨髓移植学会。
One of the major projects of the Worldwide Network for Blood and Marrow Transplantation (WBMT) is to promote hematopoietic stem cell transplantation (HSCT) in emerging countries in the world. For these countries, HLA haploidentical HSCT (haplo-HSCT) from family members is an attractive approach because of its cost effectiveness. To learn the current status, including recent trends, of haplo-HSCT, the WBMT invited speakers from major transplant centers in 3 regions (Asia, Europe, and North America) to present at its annual WBMT Joint Session. This article represents the direct reports from these 3 speakers in addition to introductions by 2 WBMT speakers who address data from the Global Transplant Activity survey. It must be emphasized, however, that certain promising results of haplo-HSCT presented in this article were obtained at well-experienced institutes. (C) 2016 American Society for Blood and Marrow Transplantation.